Mislabeled Bottles Trigger Recall of the ADHD Drug Zenzedi

2024-01-30

TUESDAY, Jan. 30, 2024 -- One lot of Zenzedi (dextroamphetamine sulfate) 30-mg tablets is being recalled after a pharmacist found antihistamine tablets (carbinoxamine) in a bottle labeled as Zenzedi, according to a recall notice issued by Azurity Pharmaceuticals Inc.

The recall comes amid an ongoing national shortage of attention-deficit/hyperactivity disorder (ADHD) drugs, creating further frustration for people with ADHD who have struggled to find medications for their condition.

The recall notice said that people who take carbinoxamine instead of Zenzedi have a higher risk for accidents or injuries and may have drowsiness, increased eye pressure, urinary obstruction, and thyroid disorder. The recalled lot has the lot number F230169A and an expiration date of June 2025.

Azurity added that it has not received any reports of serious injury related to the medication mix-up.

Consumers who have the recalled medication should return it to their pharmacy. Any adverse reactions to the drug should be reported to the U.S. Food and Drug Administration MedWatch Adverse Event Reporting program.

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Posted January 2024

More news resources

FDA Medwatch Drug Alerts

Daily MedNews

News for Health Professionals

New Drug Approvals

New Drug Applications

Drug Shortages

Clinical Trial Results

Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.